Christel A.S.Ch.A.S.BergströmChristel A.S.Ch.A.S., KristinaK.LuthmanKristinaK., PerP.ArturssonPerP., Accuracy of calculated pH-dependent aqueous drug solubility, „European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences”, 22 (5), 2004, s. 387–398, DOI: 10.1016/j.ejps.2004.04.006, PMID: 15265508 [dostęp 2021-03-23].
J.D.J.D.DunitzJ.D.J.D., H.H.EserH.H., P.P.StricklerP.P., Die Konfiguration des physiologisch wirksamen 2-Chlor-9-(?-dimethylaminopropyliden)-thioxanthens, „Helvetica Chimica Acta”, 47 (7), 1964, s. 1897–1902, DOI: 10.1002/hlca.19640470729 [dostęp 2021-03-23](niem.).
Jun-HongJ.H.Ch’ngJun-HongJ.H. i inni, A Whole Cell Pathway Screen Reveals Seven Novel Chemosensitizers to Combat Chloroquine Resistant Malaria, „Scientific Reports”, 3, 2013, DOI: 10.1038/srep01734, PMID: 23615863, PMCID: PMC3635055 [dostęp 2021-03-23].
Steffen BS.B.SchulzSteffen BS.B. i inni, First and second generation antipsychotics influence hippocampal gamma oscillations by interactions with 5-HT3 and D3 receptors, „British Journal of Pharmacology”, 167 (7), 2012, s. 1480–1491, DOI: 10.1111/j.1476-5381.2012.02107.x, PMID: 22817643, PMCID: PMC3514761 [dostęp 2021-03-23].
Neil M.N.M.RichtandNeil M.N.M. i inni, Dopamine and serotonin receptor binding and antipsychotic efficacy, „Neuropsychopharmacology”, 32 (8), 2007, s. 1715–1726, DOI: 10.1038/sj.npp.1301305, PMID: 17251913 [dostęp 2021-03-23].
B.B.FjallandB.B., V.V.BoeckV.V., Neuroleptic blockade of the effect of various neurotransmitter substances, „Acta Pharmacologica Et Toxicologica”, 42 (3), 1978, s. 206–211, DOI: 10.1111/j.1600-0773.1978.tb02191.x, PMID: 24978 [dostęp 2021-03-23].
M.M.UndénM.M., B.B.NauntofteB.B., S.S.DissingS.S., Anticholinergic effects of cis-chlorprothixene characterized in rat parotid acini, „European Journal of Pharmacology”, 164 (1), 1989, s. 129–138, DOI: 10.1016/0014-2999(89)90239-2, PMID: 2753075 [dostęp 2021-03-23].
Anton A.H.P.A.A.H.P.MegensAnton A.H.P.A.A.H.P. i inni, Differential interaction of neuroleptics with apomorphine-induced behavior in rats as a function of changing levels of dopamine receptor stimulation, „The Journal of Pharmacology and Experimental Therapeutics”, 347 (3), 2013, s. 681–696, DOI: 10.1124/jpet.113.207506, PMID: 24071734 [dostęp 2021-03-23].
B.B.Eberlein-KönigB.B., A.A.BindlA.A., B.B.PrzybillaB.B., Phototoxic properties of neuroleptic drugs, „Dermatology”, 194 (2), 1997, s. 131–135, DOI: 10.1159/000246080, PMID: 9094460 [dostęp 2021-03-23].
M.M.LuistoM.M., Polyneuropathy caused by chlorprothixene, „Acta Psychiatrica Scandinavica”, 85 (3), 1992, s. 246–248, DOI: 10.1111/j.1600-0447.1992.tb08604.x, PMID: 1314010 [dostęp 2021-03-23].
Christel A.S.Ch.A.S.BergströmChristel A.S.Ch.A.S., KristinaK.LuthmanKristinaK., PerP.ArturssonPerP., Accuracy of calculated pH-dependent aqueous drug solubility, „European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences”, 22 (5), 2004, s. 387–398, DOI: 10.1016/j.ejps.2004.04.006, PMID: 15265508 [dostęp 2021-03-23].
M.M.BagliM.M. i inni, Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparations, „Arzneimittelforschung”, 46 (3), 1996, s. 247–250, PMID: 8901143 [dostęp 2021-03-23].
Jun-HongJ.H.Ch’ngJun-HongJ.H. i inni, A Whole Cell Pathway Screen Reveals Seven Novel Chemosensitizers to Combat Chloroquine Resistant Malaria, „Scientific Reports”, 3, 2013, DOI: 10.1038/srep01734, PMID: 23615863, PMCID: PMC3635055 [dostęp 2021-03-23].
Steffen BS.B.SchulzSteffen BS.B. i inni, First and second generation antipsychotics influence hippocampal gamma oscillations by interactions with 5-HT3 and D3 receptors, „British Journal of Pharmacology”, 167 (7), 2012, s. 1480–1491, DOI: 10.1111/j.1476-5381.2012.02107.x, PMID: 22817643, PMCID: PMC3514761 [dostęp 2021-03-23].
Neil M.N.M.RichtandNeil M.N.M. i inni, Dopamine and serotonin receptor binding and antipsychotic efficacy, „Neuropsychopharmacology”, 32 (8), 2007, s. 1715–1726, DOI: 10.1038/sj.npp.1301305, PMID: 17251913 [dostęp 2021-03-23].
L.L.Antkiewicz-MichalukL.L., The influence of chronic treatment with antidepressant neuroleptics on the central serotonin system, „Polish Journal of Pharmacology and Pharmacy”, 38 (4), 1986, s. 359–370, PMID: 3774629 [dostęp 2021-03-23].
B.B.FjallandB.B., V.V.BoeckV.V., Neuroleptic blockade of the effect of various neurotransmitter substances, „Acta Pharmacologica Et Toxicologica”, 42 (3), 1978, s. 206–211, DOI: 10.1111/j.1600-0773.1978.tb02191.x, PMID: 24978 [dostęp 2021-03-23].
M.M.UndénM.M., B.B.NauntofteB.B., S.S.DissingS.S., Anticholinergic effects of cis-chlorprothixene characterized in rat parotid acini, „European Journal of Pharmacology”, 164 (1), 1989, s. 129–138, DOI: 10.1016/0014-2999(89)90239-2, PMID: 2753075 [dostęp 2021-03-23].
Anton A.H.P.A.A.H.P.MegensAnton A.H.P.A.A.H.P. i inni, Differential interaction of neuroleptics with apomorphine-induced behavior in rats as a function of changing levels of dopamine receptor stimulation, „The Journal of Pharmacology and Experimental Therapeutics”, 347 (3), 2013, s. 681–696, DOI: 10.1124/jpet.113.207506, PMID: 24071734 [dostęp 2021-03-23].
B.B.Eberlein-KönigB.B., A.A.BindlA.A., B.B.PrzybillaB.B., Phototoxic properties of neuroleptic drugs, „Dermatology”, 194 (2), 1997, s. 131–135, DOI: 10.1159/000246080, PMID: 9094460 [dostęp 2021-03-23].
M.M.LuistoM.M., Polyneuropathy caused by chlorprothixene, „Acta Psychiatrica Scandinavica”, 85 (3), 1992, s. 246–248, DOI: 10.1111/j.1600-0447.1992.tb08604.x, PMID: 1314010 [dostęp 2021-03-23].